It was reported that on (b)(6)2017, a 31mm biocor mitral valve was implanted.On a later date, the patient was reported to be experiencing hemolysis.Transthoracic echocardiogram was performed which showed moderate transvalvular regurgitation.A moderate, posterior perivalvular leak (pvl) was observed, measuring 12mm by 4mm and crescent in shape.On (b)(6)2023, two amplatzer valvular plug 3 were implanted to close the perivalvular leak.The patient was reported as stable.
|
An event of paravalular leak, hemolysis, and regurgitation about six years after the device was implanted was reported.Information from the field indicated the patient had a medical history which included persistent atrial fibrillation, infectious endocarditis and right ventricular dysfunction.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device remains implanted and was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|